What is he best known for?
The fields of study he is best known for:
His main research concerns Caenorhabditis elegans, Cell biology, Genetics, Molecular biology and Gene.
His Caenorhabditis elegans research is included under the broader classification of Biochemistry.
His Cell biology research integrates issues from Apoptosis, Programmed cell death and Anatomy.
His work in Molecular biology covers topics such as Mutation which are related to areas like Deletion Mutagenesis, Marker gene, Mutation rate and Reverse genetics.
He focuses mostly in the field of RNA interference, narrowing it down to matters related to Small interfering RNA and, in some cases, Small RNA, RNA silencing and microRNA.
His Argonaute research incorporates themes from Chromatin and RasiRNA.
His most cited work include:
- Analysis of the C. elegans Argonaute Family Reveals that Distinct Argonautes Act Sequentially during RNAi (506 citations)
- Distinct Argonaute-Mediated 22G-RNA Pathways Direct Genome Surveillance in the C. elegans Germline (347 citations)
- The Argonaute CSR-1 and Its 22G-RNA Cofactors Are Required for Holocentric Chromosome Segregation (327 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Cell biology, Caenorhabditis elegans, Genetics, Gene and Mutant.
His research in Cell biology intersects with topics in Apoptosis, Programmed cell death, RNA interference and Gene expression.
Shohei Mitani interconnects Cell and Phosphatidylserine in the investigation of issues within Apoptosis.
His research in RNA interference tackles topics such as Gene silencing which are related to areas like Small interfering RNA.
His Caenorhabditis elegans study is related to the wider topic of Biochemistry.
In his study, Functional genomics and Genome is inextricably linked to Computational biology, which falls within the broad field of Gene.
He most often published in these fields:
- Cell biology (55.03%)
- Caenorhabditis elegans (54.44%)
- Genetics (25.44%)
What were the highlights of his more recent work (between 2015-2021)?
- Cell biology (55.03%)
- Caenorhabditis elegans (54.44%)
- Gene (24.26%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Cell biology, Caenorhabditis elegans, Gene, Genetics and Biochemistry.
His Cell biology research incorporates elements of RNA interference and RNA silencing.
The various areas that he examines in his RNA interference study include Phenotype, Homologous chromosome, Transcription factor and Meiosis.
His studies deal with areas such as Small GTPase, Molecular biology, Endocytic cycle, Mitochondrion and Endosome as well as Caenorhabditis elegans.
His work on Model organism, Cas9 and Mutant as part of general Gene research is frequently linked to DPAGT1, bridging the gap between disciplines.
His Allele, CRISPR, Gpi anchored protein and Stem Cell Self-Renewal study in the realm of Genetics connects with subjects such as Gamete.
Between 2015 and 2021, his most popular works were:
- Mitochondrial endonuclease G mediates breakdown of paternal mitochondria upon fertilization (90 citations)
- Negative regulation of phosphatidylinositol 3-phosphate levels in early-to-late endosome conversion (37 citations)
- Cysteine protease cathepsin B mediates radiation-induced bystander effects (33 citations)
In his most recent research, the most cited papers focused on:
Shohei Mitani mainly investigates Caenorhabditis elegans, Cell biology, Genetics, CRISPR and Gene.
He integrates Caenorhabditis elegans with Chondroitin in his research.
Shohei Mitani mostly deals with Proteasome in his studies of Cell biology.
His work in Autophagy, Homeobox, Amphid, Phenotype and Transcription factor are all subfields of Genetics research.
He combines subjects such as Reporter gene, Mutant and Locus with his study of CRISPR.
His study in Extrachromosomal DNA, Plasmid and Transgene is carried out as part of his Gene studies.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
